| 31.12.2021 | 31.12.2020 | |
|---|---|---|
| Share capital, including: | 68,025 | 67,973 |
| Value registered at the KRS (National Court Register) | 24,123 | 24,070 |
| Shares not registered in KRS | 2 | 3 |
| Revaluation under IAS 29 | 43,900 | 43,900 |
| Number of shares registered in KRS | 9,649,392 | 9,628,197 |
| Number of shares not registered in KRS | 760 | 1,160 |
Nominal value of shares
Due to the requirements of IAS 29 Financial Reporting in Hyperinflationary Economies, the Company share capital was subject to revaluation as of the date of the first adoption of the IFRS.
In 2021, the National Court Register registered a capital increase due to the take up of 21,295 shares of H series by the management staff.
In 2020, the National Court Register registered a capital increase due to the take up of 10,500 shares of G series by the management staff, and 47,750 shares of H series by the management staff.
Moreover, as at the balance-sheet date there were 760 shares (1,160 shares as at 31 December 2020) taken up under share option plans for managerial staff, which had not yet been registered in KRS.
Rights of shareholders
All shareholders have equal rights and there are no preference shares. The Company shareholders are entitled to dividend in the declared amount. A single ordinary share entitles its holder to one vote at the Company General Meeting.
